跳至主要内容
临床试验/CTRI/2022/11/047457
CTRI/2022/11/047457尚未招募未知

A prospective interventional study to determine safety and efficacy of â??LeImmune-Tâ?? oil in improving/restoring activity of Natural Killer Cells

Phytabolites Neutraceuticals Pvt. Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • II.Healthy participants having no symptoms of Covid-19
  • III.Agree to give written consent; for minors, parents/guardians should be ready for participation
  • IV.Voluntarily participation in the clinical trial
  • V.Agreeing to follow study procedures
  • VI.Not participating in any other interventional drug clinical studies before completion of this study
  • VII.Ready to give medical data for assessments

排除标准

  • I.People with symptoms of Covid-19 / RT-PCR positive
  • II.Allergic to any ingredient of IP i.e. to Tomato or Rice Bran Oil.
  • III.Where, in the opinion of the investigator, participation in this study will not be in the best interest of the subject, or any other circumstances that prevent the subject from participating in the study safely.

研究者

发起方
Phytabolites Neutraceuticals Pvt. Ltd

相似试验